Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

6.39
Delayed Data
As of Feb 05
 +0.33 / +5.45%
Today’s Change
5.87
Today|||52-Week Range
23.39
-38.44%
Year-to-Date

Today’s Trading

Previous close6.06
Today’s open6.07
Day’s range6.04 - 6.43
Volume146,238
Average volume (3 months)266,026
Market cap$220.2M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio130.6
Price/Sales9.15
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd+0.18+1.87%
CBMGCellular Biomedicine...-0.70-3.78%
BTXBioTime Inc-0.11-4.78%
KMPHKemPharm Inc-0.52-3.50%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Bobby Dwayne Montgomery
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers